JAX in China
SHANGHAI & BEIJING
Our work in China is integral to our global mission to improve human health.
As the fastest-growing biomedical research market in the world, China is strongly positioned to make crucial contributions to human health. Thus, it is critical that Chinese researchers have access to innovative mouse models that meet a global quality standard and better represent the genetic diversity and biological complexity of the human condition.
With the goal of supporting the global research community to accelerate impactful discoveries, the JAX team in China empowers academic and drug development scientists in China by improving access to mouse models that better represent the genetic and biological complexity of the human condition, and by delivering local support and services that further the China research community’s understanding of human genomics and the use of model systems to uncover cures for disease.
In December, 2020, we announced the establishment of a joint venture company headquartered in Beijing, China. The newly constructed facility will increase accessibility and provide researchers in China with a more economical, convenient and immediate supply of JAX® Mice.